Correlation Between West Pharmaceutical and Sanara Medtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both West Pharmaceutical and Sanara Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining West Pharmaceutical and Sanara Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between West Pharmaceutical Services and Sanara Medtech, you can compare the effects of market volatilities on West Pharmaceutical and Sanara Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in West Pharmaceutical with a short position of Sanara Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of West Pharmaceutical and Sanara Medtech.

Diversification Opportunities for West Pharmaceutical and Sanara Medtech

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between West and Sanara is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding West Pharmaceutical Services and Sanara Medtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanara Medtech and West Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on West Pharmaceutical Services are associated (or correlated) with Sanara Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanara Medtech has no effect on the direction of West Pharmaceutical i.e., West Pharmaceutical and Sanara Medtech go up and down completely randomly.

Pair Corralation between West Pharmaceutical and Sanara Medtech

Considering the 90-day investment horizon West Pharmaceutical is expected to generate 3.14 times less return on investment than Sanara Medtech. But when comparing it to its historical volatility, West Pharmaceutical Services is 1.15 times less risky than Sanara Medtech. It trades about 0.06 of its potential returns per unit of risk. Sanara Medtech is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  3,345  in Sanara Medtech on September 5, 2024 and sell it today you would earn a total of  291.00  from holding Sanara Medtech or generate 8.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

West Pharmaceutical Services  vs.  Sanara Medtech

 Performance 
       Timeline  
West Pharmaceutical 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in West Pharmaceutical Services are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, West Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Sanara Medtech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sanara Medtech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Sanara Medtech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

West Pharmaceutical and Sanara Medtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with West Pharmaceutical and Sanara Medtech

The main advantage of trading using opposite West Pharmaceutical and Sanara Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if West Pharmaceutical position performs unexpectedly, Sanara Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanara Medtech will offset losses from the drop in Sanara Medtech's long position.
The idea behind West Pharmaceutical Services and Sanara Medtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets